An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

Title

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

Authors

Keywords

-

Journal

AMERICAN HEART JOURNAL

Volume 169, Issue 4, Pages 472-478.e5

Publisher

Elsevier BV

Online

2014-12-20

DOI

10.1016/j.ahj.2014.12.006